Nancy Davidson
Insider
First SEC filing: Dec. 8, 2023 · Latest: Dec. 8, 2023
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net: $0
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Dec. 10, 2024 | ZYME | A | 31,000 | · | · | 31,000 Direct | · | Acquired | (price as of 2026-10-02) |
| Dec. 7, 2023 | ZYME | A | 74,000 | · | · | 74,000 Direct | · | Acquired | (price as of 2026-10-02) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Dec. 10, 2024 | ZYME | Stock Option (Right to Buy) | Common Stock | $13.06 | Dec. 9, 2034 | 31,000 | Acquired |
| Dec. 7, 2023 | ZYME | Stock Option (Right to Buy) | Common Stock | $9.55 | Dec. 6, 2033 | 74,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 2 holdings
Securities held when first becoming an insider, per SEC Form 3.